Metabolic Activation With Protein-rich Formula Diet
AVS
1 other identifier
interventional
300
1 country
1
Brief Summary
Formerly, the investigators demonstrated in an uncontrolled proof-of principle study (NCT 01680926) that protein-rich meal replacement (PRMR) was successful in reducing daily insulin demand, HbA1c and weight in type 2 diabetes mellitus (T2DM) patients injecting \>100 IE insulin/day. The aim of the present study was to investigate in a randomized-controlled trial if PRMR is also effective in T2DM patients treated with oral antidiabetic medication or insulin. A second part of the study is an open-label registry for persons with type 2 diabetes, who will perform the lifestyle intervention with the stringent diet regime.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable type-2-diabetes-mellitus
Started Feb 2011
Longer than P75 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 26, 2014
CompletedFirst Posted
Study publicly available on registry
September 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedJanuary 23, 2024
January 1, 2024
12.9 years
August 26, 2014
January 22, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
HbA1c
change in hemoglobin A1c
12 weeks
Secondary Outcomes (9)
HbA1c
1 year
body weight
12 weeks and 1 year
blood pressure
12 weeks and 1 year
cholesterol
12 weeks and 1 year
fasting blood glucose
12 weeks and 1 year
- +4 more secondary outcomes
Study Arms (2)
moderate diet regimen
EXPERIMENTALWeek 1-4: replacement of breakfast and dinner with 1g PRMR /kg normal weight (=height in cm-100), a protein-rich lunch was allowed Week 5-12: replacement of dinner For this arm a local subgroup (n=55) and a nation-wide subgroup (n=100) is planned.
stringent diet regimen
EXPERIMENTALWeek 1: replacement of 3 main meals by 1g PRMR / kg normal weight (=height in cm - 100) Week 2-4: replacement of breakfast and dinner, a protein-rich lunch was allowed Week 5-12: replacement of dinner For this arm a local subgroup (n=55) and a nation-wide subgroup (n=100) is planned.
Interventions
Eligibility Criteria
You may qualify if:
- Type 2 diabetes mellitus
- HbA1c \> 7,5%
- Body Mass Index (BMI) ≥ 27,5 kg/m2
You may not qualify if:
- acute infections
- severe diseased with hospital stay during the last 3 months
- chronic diseases
- chemotherapy or cortisone treatment
- weight loss of more than 2 kg per week during the last month
- smoking cessation during the last 3 months or planned
- weight-influencing medication
- pregnancy, breast-feeding or lack of contraception
- high-level physical activity of more than 1h per day
- incompatibility with components of the PRMR
- participation in an other study during the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- West German Center of Diabetes and Healthlead
- Almased Wellness GmbHcollaborator
Study Sites (1)
West German Centre of Diabetes and Health
Düsseldorf, 40591, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- For the second part of the study, i.e. the open-label registry, 4000 subjects are anicipated.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
August 26, 2014
First Posted
September 3, 2014
Study Start
February 1, 2011
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
January 23, 2024
Record last verified: 2024-01